Abstract
Serum human growth hormone (HGH), serum immunoreactive insulin (IRI), plasma free fatty acids, and blood glucose were measured during intravenous glucose and intravenous tolbutamide tolerance tests in 13 normal and 13 prediabetic (offspring of two diabetic parents) males, closely matched for weight and age. Only prediabetics with normal glucose tolerance during oral, intravenous, and cortisone-primed glucose tolerance tests were evaluated.
Mean serum HGH levels were significantly higher in prediabetics in response to intravenous tolbutamide and at the end of the 3-hr intravenous glucose tolerance tests (IVGTT). This is interpreted as a hyperresponsiveness of the growth hormone-releasing mechanisms in prediabetic subjects.
The insulin response during the first 10 min of an IVGTT was significantly reduced in prediabetic males as compared to normal controls, whereas the insulin response to intravenous tolbutamide was not significantly different at the same time intervals in the same subjects.
It appears, therefore, that measuring IRI during an IVGTT can be valuable in detecting the earliest signs of diabetes even before any disturbance of blood glucose homeostasis is seen.
The possibility that growth hormone hypersecretion in prediabetics might play a role in the pathogenesis of human diabetes mellitus is discussed.
Full text
PDF![729](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/0a9f547f64a3/jcinvest00239-0075.png)
![730](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/e46cc91b41fe/jcinvest00239-0076.png)
![731](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/60cb4636c356/jcinvest00239-0077.png)
![732](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/18a027ebc2b1/jcinvest00239-0078.png)
![733](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/c7781042eb78/jcinvest00239-0079.png)
![734](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/e07fc6ab85df/jcinvest00239-0080.png)
![735](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/a94700fc9022/jcinvest00239-0081.png)
![736](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/6d9946349de7/jcinvest00239-0082.png)
![737](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/ac9a60774c3b/jcinvest00239-0083.png)
![738](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/a876e57fdd99/jcinvest00239-0084.png)
![739](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f444/297224/733db5fda7e5/jcinvest00239-0085.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Beck P., Schalch D. S., Parker M. L., Kipnis D. M., Daughaday W. H. Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med. 1965 Sep;66(3):366–379. [PubMed] [Google Scholar]
- Boden G., Soeldner J. S. A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion. Diabetologia. 1967 Oct;3(5):413–421. doi: 10.1007/BF01228076. [DOI] [PubMed] [Google Scholar]
- CAMERINI D AVALOS R. A., CAULFIELD J. B., REES S. B., LOZANO CASTANEDA O., NALDJIAN S., MARBLE A. PRELIMINARY OBSERVATIONS ON SUBJECTS WITH PREDIABETES. Diabetes. 1963 Nov-Dec;12:508–518. doi: 10.2337/diab.12.6.508. [DOI] [PubMed] [Google Scholar]
- CONN J. W., FAJANS S. S. The prediabetic state. A concept of dynamic resistance to a genetic diabetogenic influence. Am J Med. 1961 Dec;31:839–850. doi: 10.1016/0002-9343(61)90023-7. [DOI] [PubMed] [Google Scholar]
- CONN J. W. The prediabetic state in man; definition, interpretation and implications. Diabetes. 1958 Sep-Oct;7(5):347–357. doi: 10.2337/diab.7.5.347. [DOI] [PubMed] [Google Scholar]
- Colwell J. A., Lein A. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes. 1967 Aug;16(8):560–565. doi: 10.2337/diab.16.8.560. [DOI] [PubMed] [Google Scholar]
- DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
- FAJANS S. S., CONN J. W. An approach to the prediction of diabetes mellitus by modification of the glucose tolerance test with cortisone. Diabetes. 1954 Jul-Aug;3(4):296-302; discussion, 302-4. doi: 10.2337/diab.3.4.296. [DOI] [PubMed] [Google Scholar]
- GLICK S. M., ROTH J., YALOW R. S., BERSON S. A. THE REGULATION OF GROWTH HORMONE SECRETION. Recent Prog Horm Res. 1965;21:241–283. [PubMed] [Google Scholar]
- Perley M., Kipnis D. M. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes. 1966 Dec;15(12):867–874. doi: 10.2337/diab.15.12.867. [DOI] [PubMed] [Google Scholar]
- STEINBERG A. G. The genetics of diabetes: a review. Ann N Y Acad Sci. 1959 Sep 25;82:197–207. doi: 10.1111/j.1749-6632.1959.tb44900.x. [DOI] [PubMed] [Google Scholar]
- STEINKE J., SOELDNER J. S., CAMERINI D AVALOS R. A., RENOLD A. E. STUDIES ON SERUM INSULIN-LIKE ACTIVITY (ILA) IN PREDIABETES AND EARLY OVERT DIABETES. Diabetes. 1963 Nov-Dec;12:502–507. doi: 10.2337/diab.12.6.502. [DOI] [PubMed] [Google Scholar]
- Seltzer H. S., Allen E. W., Herron A. L., Jr, Brennan M. T. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967 Mar;46(3):323–335. doi: 10.1172/JCI105534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Siperstein M. D., Norton W., Unger R. H., Madison L. L. Muscle capillary basement membrane width in normal, diabetic and prediabetic patients. Trans Assoc Am Physicians. 1966;79:330–347. [PubMed] [Google Scholar]
- Soeldner J. S., Gleason R. E., Williams R. F., Garcia M. J., Beardwood D. M., Marble A. Diminished serum insulin response to glucose in genetic prediabetic males with normal glucose tolerance. Diabetes. 1968 Jan;17(1):17–26. doi: 10.2337/diab.17.1.17. [DOI] [PubMed] [Google Scholar]
- Soeldner J. S., Slone D. Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes. 1965 Dec;14(12):771–779. doi: 10.2337/diab.14.12.771. [DOI] [PubMed] [Google Scholar]
- YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- YALOW R. S., BERSON S. A. Plasma insulin concentrations in nondiabetic and early diabetic subjects. Determinations by a new sensitive immuno-assay technic. Diabetes. 1960 Jul-Aug;9:254–260. doi: 10.2337/diab.9.4.254. [DOI] [PubMed] [Google Scholar]
- Young F. G. The diabetogenic action of crude anterior pituitary extracts. Biochem J. 1938 Mar;32(3):513–523. doi: 10.1042/bj0320513. [DOI] [PMC free article] [PubMed] [Google Scholar]